The global lyophilized injectable market is projected to register at a moderate-paced (Compound Annual Growth Rate) CAGR of 5.8% over the forecast period. The lyophilized injectable market is currently valued at USD 3043.55 Million in 2023. By 2033, demand for lyophilized injectables is expected to reach a high of USD 5348.56 Million.
This growth in the adoption of lyophilized injectables is supported by the following:
Trials that are still going on are revealing added information about the safety and effectiveness of new lyophilized medicines that are being used to treat COVID-19. Manufacturers in the global lyophilized injectable market are getting licenses from the USA Food and Drug Administration (FDA) for the Emergency Use Authorization (EUA) of these products so they can treat people with severe COVID-19 symptoms.
Since the COVID-19 pandemic, companies that export lyophilized injectables have worked harder to obtain authorization from authorities like the Drug Controller General of India (DCGI) so that their goods may be used in India for limited emergency purposes. As more medications, like Remdesivir, get approved, the need for lyophilized injections will inevitably rise. The Food and Drug Administration (FDA) and other regulatory agencies have given their approvals for the following:
As a result, the expansion of the market for lyophilized injections is being driven by the rising number of approvals being granted all over the world.
| Attribute | Details |
|---|---|
| Market Value (2023) | USD 3043.55 Million |
| Market Value (2033) | USD 5348.56 Million |
| CAGR (2023 to 2033) | 5.8% |
There has been a significant increase in the number of businesses throughout the world using lyophilization technology because of the superior quality and longer shelf life of lyophilized medications. There has been a substantial uptick in the utilization of lyophilized injection pharmaceuticals by global contract research and manufacturing firms during the past few years. The primary motivation for this change is to supply final consumers with better goods. Opportunities in the global lyophilized injectable market are being created by reasons such as the fast growth of Contract Research Manufacturing Services (CRAMS).
Due to their safety and capacity to fulfill their stated functions, lyophilized products have witnessed a substantial increase in usage recently compared to non-lyophilized ones. Besides this, the cold chain is not necessary for these items. Therefore, they contribute to lower carbon footprints and total expenses. As a result of these factors, the lyophilized injectable market is predicted to expand into new lucrative areas in the coming years.
The expansion of the sector for lyophilized injection drugs may be hampered by several incidents involving the recall of products containing complex medications. In recent years, there has been a significant increase in product recalls that have been reported by manufacturers. These recalls have been brought about by the presence of unwanted foreign substances or by adverse drug effects. Recalls have the potential to harm a company's reputation as well as its ability to generate revenue.
It is anticipated that the injection supplies pharmaceuticals market coming from the retail pharmacy segment is anticipated to hold more than 30 percent of the total industry share by 2033. As they provide convenient access, cheap rates, high-end customer care, and an extensive selection of items, retail pharmacies have emerged as one of the primary distribution channels. This is because retail pharmacies offer all these benefits.
In addition to this, pharmacies and other retail locations sell pharmaceuticals and offer individuals individualized guidance that caters to their specific healthcare issues and needs. In recent years, there has been a considerable increase in the number of retail pharmacies as well as pharmacy chains, which is indicative of a strong preference among customers for this type of distribution channel.
It is anticipated that the demand for lyophilized injectable medicines in the prefilled device category is likely to reach USD 210 Billion by 2033. Prefilled devices are becoming increasingly popular because of their ability to reduce the amount of time that patients are required to wait during hospital visits and to improve the level of medical care.
Along with ensuring the safe and convenient delivery of treatment, it also guarantees an elevated level of precision in the dosing of medications. Although the introduction of prefilled devices across a spectrum of drug classes and therapeutic categories can look quite different, it is anticipated that demand for the product is likely to remain steady.
The lyophilized Injectable market is estimated to grow profitably in North America in the upcoming years because of the rising frequency of disorders in the United States. . The presence of significant manufacturers, like Fresenius Kabi and Merck & Co. Inc., and Amneal Pharmaceutical, both are involved in the production of lyophilized injections and helping to drive growth in the USA Lyophilized Injectable Market. Furthermore, the increasing number of product approvals made by regulatory authorities in North America is anticipated to be fueling the expansion of the USA Lyophilized Injectable Market.
It is expected that the size of the lyophilized injectable market in Europe is expected to exceed USD 185 Billion by 2030. This region is predicted to become a suitable region for the expansion of existing businesses due to the rising incidence of cancer and other ailments. Europe, which has one of the oldest populations overall, is home to some of the world's oldest individuals. The growth of the senior population, which has a compromised immunological and metabolic system and is consequently at a higher risk of developing life-threatening illnesses, is another significant factor that is projected to propel the sector. According to several studies, the native populations of Belgium, the Netherlands, Denmark, and Ireland have the greatest incidence of cancer patients compared to that of any other European nation.
The coronavirus has grown to pose a significant threat to public health because it causes such severe respiratory symptoms and is ever-evolving. Adult hospitalized patients with COVID-19 are the focus of ongoing research on the efficacy and safety of novel lyophilized treatment medicines. Within this context, Cipla, a worldwide pharmaceutical business, is getting attention for releasing CIPREMI, a remdesivir lyophilized powder for injection (100 mg). Manufacturers in the lyophilized injectable market are adopting cues from these developments to enhance access to the Emergency Use Authorization (EUA) medication approved by the USA Food and Drug Administration for people experiencing severe COVID-19 symptoms.
With the third wave of the pandemic hitting India, manufacturers in the lyophilized injections industry there are stepping up their efforts to secure regulatory permission from the Drug Controller General of India (DCGI) for limited emergency use in the country.
Major players catering to the global demand for lyophilized injectables are showing a rising interest in the creation of drug delivery systems that are universal, upgradeable, and configurable. To do this, they are putting a significant amount of money into research and development-related operations.
A trend toward the incorporation of electronic components into injectors and other types of devices is likely to emerge among industry participants in the years to come. It is anticipated that these capabilities are expected to permit modification as per the user type that is proposed. Soon, it's anticipated that these devices' networking capabilities will allow for remote upgrades. As of this element, the process of managing the lifecycle of these devices is anticipated to become less difficult.
Key players in this industry rely on a strategy of continuous product development and improvement to meet the needs of their clients throughout the world and maintain their reputation in the cutthroat global lyophilized injectable market. In April of 2022, for instance, Recipharm purchased both the advanced therapy CDMO (Contract Development and Manufacturing Organization) Arranta Bio and the virotherapy CDMO Vibalogics. As a result of the purchase, Recipharm now has a sturdy foundation in the USA owing to its new Boxborough, Massachusetts facilities, and a solid foundation upon which to expand its capabilities into other biologics modalities.
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Type of Packaging, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by Type of Delivery, 2017 to 2032
Table 4: Global Market Value (US$ Million) Forecast by Indication, 2017 to 2032
Table 5: Global Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 7: North America Market Value (US$ Million) Forecast by Type of Packaging, 2017 to 2032
Table 8: North America Market Value (US$ Million) Forecast by Type of Delivery, 2017 to 2032
Table 9: North America Market Value (US$ Million) Forecast by Indication, 2017 to 2032
Table 10: North America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 12: Latin America Market Value (US$ Million) Forecast by Type of Packaging, 2017 to 2032
Table 13: Latin America Market Value (US$ Million) Forecast by Type of Delivery, 2017 to 2032
Table 14: Latin America Market Value (US$ Million) Forecast by Indication, 2017 to 2032
Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 17: Europe Market Value (US$ Million) Forecast by Type of Packaging, 2017 to 2032
Table 18: Europe Market Value (US$ Million) Forecast by Type of Delivery, 2017 to 2032
Table 19: Europe Market Value (US$ Million) Forecast by Indication, 2017 to 2032
Table 20: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 22: Asia Pacific Market Value (US$ Million) Forecast by Type of Packaging, 2017 to 2032
Table 23: Asia Pacific Market Value (US$ Million) Forecast by Type of Delivery, 2017 to 2032
Table 24: Asia Pacific Market Value (US$ Million) Forecast by Indication, 2017 to 2032
Table 25: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 26: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 27: MEA Market Value (US$ Million) Forecast by Type of Packaging, 2017 to 2032
Table 28: MEA Market Value (US$ Million) Forecast by Type of Delivery, 2017 to 2032
Table 29: MEA Market Value (US$ Million) Forecast by Indication, 2017 to 2032
Table 30: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2032
Figure 1: Global Market Value (US$ Million) by Type of Packaging, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Type of Delivery, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Indication, 2022 to 2032
Figure 4: Global Market Value (US$ Million) by End User, 2022 to 2032
Figure 5: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 9: Global Market Value (US$ Million) Analysis by Type of Packaging, 2017 to 2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Type of Packaging, 2022 to 2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Type of Packaging, 2022 to 2032
Figure 12: Global Market Value (US$ Million) Analysis by Type of Delivery, 2017 to 2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Type of Delivery, 2022 to 2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Type of Delivery, 2022 to 2032
Figure 15: Global Market Value (US$ Million) Analysis by Indication, 2017 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 18: Global Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 21: Global Market Attractiveness by Type of Packaging, 2022 to 2032
Figure 22: Global Market Attractiveness by Type of Delivery, 2022 to 2032
Figure 23: Global Market Attractiveness by Indication, 2022 to 2032
Figure 24: Global Market Attractiveness by End User, 2022 to 2032
Figure 25: Global Market Attractiveness by Region, 2022 to 2032
Figure 26: North America Market Value (US$ Million) by Type of Packaging, 2022 to 2032
Figure 27: North America Market Value (US$ Million) by Type of Delivery, 2022 to 2032
Figure 28: North America Market Value (US$ Million) by Indication, 2022 to 2032
Figure 29: North America Market Value (US$ Million) by End User, 2022 to 2032
Figure 30: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 34: North America Market Value (US$ Million) Analysis by Type of Packaging, 2017 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Type of Packaging, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Type of Packaging, 2022 to 2032
Figure 37: North America Market Value (US$ Million) Analysis by Type of Delivery, 2017 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Type of Delivery, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Type of Delivery, 2022 to 2032
Figure 40: North America Market Value (US$ Million) Analysis by Indication, 2017 to 2032
Figure 41: North America Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 43: North America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 46: North America Market Attractiveness by Type of Packaging, 2022 to 2032
Figure 47: North America Market Attractiveness by Type of Delivery, 2022 to 2032
Figure 48: North America Market Attractiveness by Indication, 2022 to 2032
Figure 49: North America Market Attractiveness by End User, 2022 to 2032
Figure 50: North America Market Attractiveness by Country, 2022 to 2032
Figure 51: Latin America Market Value (US$ Million) by Type of Packaging, 2022 to 2032
Figure 52: Latin America Market Value (US$ Million) by Type of Delivery, 2022 to 2032
Figure 53: Latin America Market Value (US$ Million) by Indication, 2022 to 2032
Figure 54: Latin America Market Value (US$ Million) by End User, 2022 to 2032
Figure 55: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 59: Latin America Market Value (US$ Million) Analysis by Type of Packaging, 2017 to 2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Type of Packaging, 2022 to 2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Type of Packaging, 2022 to 2032
Figure 62: Latin America Market Value (US$ Million) Analysis by Type of Delivery, 2017 to 2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Type of Delivery, 2022 to 2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Type of Delivery, 2022 to 2032
Figure 65: Latin America Market Value (US$ Million) Analysis by Indication, 2017 to 2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 71: Latin America Market Attractiveness by Type of Packaging, 2022 to 2032
Figure 72: Latin America Market Attractiveness by Type of Delivery, 2022 to 2032
Figure 73: Latin America Market Attractiveness by Indication, 2022 to 2032
Figure 74: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 75: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 76: Europe Market Value (US$ Million) by Type of Packaging, 2022 to 2032
Figure 77: Europe Market Value (US$ Million) by Type of Delivery, 2022 to 2032
Figure 78: Europe Market Value (US$ Million) by Indication, 2022 to 2032
Figure 79: Europe Market Value (US$ Million) by End User, 2022 to 2032
Figure 80: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 84: Europe Market Value (US$ Million) Analysis by Type of Packaging, 2017 to 2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Type of Packaging, 2022 to 2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Type of Packaging, 2022 to 2032
Figure 87: Europe Market Value (US$ Million) Analysis by Type of Delivery, 2017 to 2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Type of Delivery, 2022 to 2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Type of Delivery, 2022 to 2032
Figure 90: Europe Market Value (US$ Million) Analysis by Indication, 2017 to 2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 96: Europe Market Attractiveness by Type of Packaging, 2022 to 2032
Figure 97: Europe Market Attractiveness by Type of Delivery, 2022 to 2032
Figure 98: Europe Market Attractiveness by Indication, 2022 to 2032
Figure 99: Europe Market Attractiveness by End User, 2022 to 2032
Figure 100: Europe Market Attractiveness by Country, 2022 to 2032
Figure 101: Asia Pacific Market Value (US$ Million) by Type of Packaging, 2022 to 2032
Figure 102: Asia Pacific Market Value (US$ Million) by Type of Delivery, 2022 to 2032
Figure 103: Asia Pacific Market Value (US$ Million) by Indication, 2022 to 2032
Figure 104: Asia Pacific Market Value (US$ Million) by End User, 2022 to 2032
Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Type of Packaging, 2017 to 2032
Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Type of Packaging, 2022 to 2032
Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Type of Packaging, 2022 to 2032
Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Type of Delivery, 2017 to 2032
Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Type of Delivery, 2022 to 2032
Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Type of Delivery, 2022 to 2032
Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Indication, 2017 to 2032
Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 118: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 121: Asia Pacific Market Attractiveness by Type of Packaging, 2022 to 2032
Figure 122: Asia Pacific Market Attractiveness by Type of Delivery, 2022 to 2032
Figure 123: Asia Pacific Market Attractiveness by Indication, 2022 to 2032
Figure 124: Asia Pacific Market Attractiveness by End User, 2022 to 2032
Figure 125: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 126: MEA Market Value (US$ Million) by Type of Packaging, 2022 to 2032
Figure 127: MEA Market Value (US$ Million) by Type of Delivery, 2022 to 2032
Figure 128: MEA Market Value (US$ Million) by Indication, 2022 to 2032
Figure 129: MEA Market Value (US$ Million) by End User, 2022 to 2032
Figure 130: MEA Market Value (US$ Million) by Country, 2022 to 2032
Figure 131: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 134: MEA Market Value (US$ Million) Analysis by Type of Packaging, 2017 to 2032
Figure 135: MEA Market Value Share (%) and BPS Analysis by Type of Packaging, 2022 to 2032
Figure 136: MEA Market Y-o-Y Growth (%) Projections by Type of Packaging, 2022 to 2032
Figure 137: MEA Market Value (US$ Million) Analysis by Type of Delivery, 2017 to 2032
Figure 138: MEA Market Value Share (%) and BPS Analysis by Type of Delivery, 2022 to 2032
Figure 139: MEA Market Y-o-Y Growth (%) Projections by Type of Delivery, 2022 to 2032
Figure 140: MEA Market Value (US$ Million) Analysis by Indication, 2017 to 2032
Figure 141: MEA Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032
Figure 142: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032
Figure 143: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 144: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 145: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 146: MEA Market Attractiveness by Type of Packaging, 2022 to 2032
Figure 147: MEA Market Attractiveness by Type of Delivery, 2022 to 2032
Figure 148: MEA Market Attractiveness by Indication, 2022 to 2032
Figure 149: MEA Market Attractiveness by End User, 2022 to 2032
Figure 150: MEA Market Attractiveness by Country, 2022 to 2032
The growth outlook for the Lyophilized Injectable market is predicted to advance at a CAGR of 5.8% from 2022 to 2032.
Europe region is anticipated to lead the Lyophilized Injectable market over the forecast period.
The valuation of the Lyophilized Injectable market stands at USD 3043.55 Million in 2023.
The Lyophilized Injectable market is likely to hold a valuation of USD 5348.56 Million by 2033.
Explore Similar Insights
Lyophilized Injectable Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
